China Universal Asset Management Co., Ltd. increased its shareholding in Keymed Biosciences-B (02162.HK) by 242,000 shares at approximately HK$87.96 per share.

Zhitong Finance APP has learned that the latest data from the Hong Kong Stock Exchange shows that on October 21, China Universal Asset Management Co., Ltd. increased its holdings of Keymed Biosciences-B (02162.HK) by 242,000 shares at HK$87.9628 per share, for a total amount of approximately HK$21.287 million. After the increase, its latest shareholding was 14.999 million shares, with its latest shareholding ratio at 5.02%.